Vanda Pharmaceuticals, Inc. (VNDA)
7.12
-1.45
(-16.92%)
USD |
NASDAQ |
Mar 20, 16:00
7.09
-0.03
(-0.42%)
After-Hours: 20:00
Vanda Pharmaceuticals Research and Development Expense (Quarterly) : 29.01M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Eli Lilly & Co. | 3.802B |
| Gilead Sciences, Inc. | 1.565B |
| Axsome Therapeutics, Inc. | 48.68M |
| Gossamer Bio, Inc. | 48.93M |
| Arcellx, Inc. | 34.10M |